Comprehensive medical oncology care with modern systemic therapies: chemotherapy, targeted drugs, immunotherapy, hormonal blockade, and biomarker-directed precision medicine at American Oncology Institute, Aarvy Hospital, Sector-90, Gurgaon.
Select a cancer category below to explore specific biomarker targets, systemic therapies, and clinical pathways managed by Dr. Janki Choudhary.
Personalised systemic care across hormone-receptor positive (HR+), HER2-directed, and triple-negative breast cancers (TNBC).
Comprehensive evaluation for Non-Small Cell (NSCLC) and Small Cell (SCLC) lung cancers with actionable driver mutations.
Medical management for ovarian, cervical, uterine, and endometrial malignancies with intraperitoneal/systemic protocols.
Oral cavity, tongue, pharynx & larynx cancers with concurrent chemoradiotherapy coordination and targeted therapy.
Colorectal, stomach, esophageal, pancreatic & hepatobiliary malignancies treated with multimodal regimens.
Advanced medical protocols for prostate, urinary bladder, renal cell (RCC), and testicular neoplasms.
Specialized chemotherapy and targeted regimens for soft tissue sarcomas, bone sarcomas, and GISTs.
Systemic management of Hodgkin and Non-Hodgkin Lymphomas, Multiple Myeloma, and comprehensive supportive care.
Click on any treatment approach below to see how it works, its method of administration, and proactive tolerability management.
Chemotherapy utilizes powerful cytotoxic drugs delivered systemically into the bloodstream to target and destroy rapidly dividing cancer cells, prevent tumor recurrence after surgery (adjuvant), or shrink tumors beforehand (neoadjuvant).
Administered with modern anti-nausea premedications (5-HT3 and NK1 receptor antagonists), cold-cap scalp cooling coordination, and painless Chemoport access for maximum comfort.
Breast, Lung, Colorectal, Ovarian, Head & Neck cancers, Sarcomas, and Lymphomas across curative and palliative settings.
How Next-Generation Sequencing (NGS) and molecular tumor genetics translate into tailored clinical decisions.
Precise histopathology biopsy review, TNM staging scans, and multidisciplinary tumor board staging.
Targeted molecular panels or Next-Generation Sequencing (NGS) to detect actionable mutations and fusions.
Matching the identified molecular signature to approved targeted inhibitors, immunotherapy, or clinical trials.
Therapy execution with diligent monitoring of response, blood counts, tolerance, and ongoing surveillance.
Select your primary condition and consultation objective to receive an immediate checklist of diagnostic reports to bring and tailored guidance for your visit.
Biopsy histopathology slides & blocks, IHC receptor report (ER/PR/HER2), PET-CT scan CD and film, and recent complete blood count (CBC, LFT, KFT).
Is neoadjuvant chemotherapy or surgery recommended first? What is the role of HER2-targeted therapy or genetic BRCA testing in my individual case?
* This tool is for consultation preparation only and does not provide medical diagnosis or treatment advice.
Simple, reliable information to help patients and families understand cancer care.
How medical oncologists plan and coordinate systemic therapies for cancer patients.
Clear explanation of how chemotherapy works, what to expect, and supportive care measures.
How modern immunotherapy helps the body's immune system recognize and respond to cancer cells.
How molecular profiling and NGS assist in identifying targeted treatment options.
Checklist of biopsy reports, imaging scans, and medical history documents for your visit.
How targeted medicines focus on specific biological markers in cancer cells.
